Video Experimental Relacionado
Updated: Sep 9, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.5K
El uso a largo plazo de aspirina y la incidencia de insuficiencia cardíaca: un estudio de análisis combinado a nivel
Mianli Xiao1, Zailing Xing1, Douglas Schocken2
1Department of Epidemiology, College of Public Health, University of South Florida, Tampa, Florida, USA.
The American journal of medicine
|September 2, 2025
Resumen
El uso crónico de aspirina se relacionó con un mayor riesgo de desarrollar insuficiencia cardíaca en individuos sin enfermedad cardiovascular previa. Por el contrario, evitar la aspirina se asoció con un riesgo reducido de insuficiencia cardíaca.
Área de la Ciencia:
- Medicina cardiovascular
- Epidemiología
- Farmacología
Sus antecedentes:
- El impacto del uso a largo plazo de aspirina en el desarrollo de la insuficiencia cardíaca no se comprende bien.
- Los estudios anteriores no han evaluado el uso de aspirina como una exposición dependiente del tiempo para el riesgo de insuficiencia cardíaca.
Objetivo del estudio:
- Evaluar el efecto del uso crónico de aspirina en la incidencia de insuficiencia cardíaca.
- Para evaluar el riesgo de insuficiencia cardíaca asociado con el uso constante de aspirina frente a nunca usar aspirina.
Principales métodos:
- Análisis de los datos de cuatro estudios prospectivos de cohorte con 26.941 participantes en riesgo de insuficiencia cardíaca.
- Seguimiento longitudinal de la insuficiencia cardíaca incidente, con recopilación de datos dependientes del tiempo sobre el uso de aspirina y los factores de riesgo.
- Utilizó la fórmula g paramétrica para estimar el impacto de las intervenciones hipotéticas de uso de aspirina.
Principales resultados:
- Durante una mediana de 14,8 años, se registraron 5.899 casos de insuficiencia cardíaca.
- El uso continuo de aspirina se asoció con un aumento del 7% en el riesgo de insuficiencia cardíaca (RR 1, 07).
- El hecho de no haber usado nunca aspirina se asoció con una disminución del 6% en el riesgo de insuficiencia cardíaca (RR 0,94).
Conclusiones:
- El uso prolongado de aspirina aumenta el riesgo de insuficiencia cardíaca en personas sin enfermedad cardiovascular preexistente.
- Los hallazgos ponen de relieve un efecto adverso potencial del uso crónico de aspirina en la salud del corazón.
- La fórmula g proporciona un método sólido para estimar los efectos de exposición dependientes del tiempo.
Palabras clave:
Las aspirinasRiesgo cardiovascularInferencia causalFallo cardíacoUso a largo plazoAnálisis combinadoMás Videos Relacionados
Videos de Conceptos Relacionados
01:30Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
01:22Heart Failure Drugs: β-Blockers
434
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
434
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:27Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:30Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139